IMNM · Immunome Inc.
$28.52
+0.44 (+1.57%)
At close · Aug 21
Market Cap
$3.24B
Shares
113.58M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-11 | — | |
| 10-Q | 2026-08-11 | 2026-06-30 | |
| 8-K | 2026-06-12 | 2026-06-09 | |
| Investor Event Transcript | 2026-06-09 | 2026-06-30 | |
| 8-K | 2026-05-12 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| DEF 14A | 2026-04-24 | 2026-06-09 | |
| 8-K | 2026-03-03 | — | |
| 10-K | 2026-03-03 | 2025-12-31 | |
| 8-K | 2025-12-17 | 2025-12-16 | |
| 8-K | 2025-12-15 | — | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-06-11 | 2025-06-10 | |
| 8-K | 2025-05-12 | 2025-05-08 | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| DEF 14A | 2025-04-24 | 2025-06-10 | |
| 10-K | 2025-03-19 | 2024-12-31 | |
| 8-K | 2025-03-19 | — | |
| 8-K | 2025-01-30 | 2025-01-29 | |
| 8-K | 2025-01-29 | — | |
| 8-K | 2025-01-23 | 2025-01-21 | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-11-13 | — | |
| 8-K | 2024-10-29 | 2024-10-25 | |
| 8-K | 2024-10-08 | 2024-10-03 | |
| 10-Q | 2024-08-12 | 2024-06-30 | |
| 8-K | 2024-08-12 | — | |
| 8-K | 2024-06-13 | 2024-06-12 | |
| 8-K | 2024-05-14 | — | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| 8-K | 2024-04-30 | 2024-04-24 | |
| DEF 14A | 2024-04-26 | 2024-06-12 | |
| 8-K | 2024-04-25 | — | |
| 10-K | 2024-03-28 | 2023-12-31 | |
| 8-K | 2024-03-28 | — | |
| 8-K | 2024-03-26 | 2024-03-25 | |
| 8-K | 2024-02-14 | 2024-02-13 | |
| 8-K | 2024-02-13 | — | |
| 8-K | 2024-02-06 | 2024-02-05 | |
| 8-K | 2024-02-01 | 2024-01-31 | |
| 8-K | 2024-01-11 | — | |
| 8-K | 2024-01-08 | 2024-01-05 | |
| 8-K | 2024-01-02 | — | |
| 8-K | 2023-12-29 | 2023-12-22 | |
| 8-K | 2023-12-26 | 2023-12-22 | |
| 8-K/A | 2023-11-22 | 2023-09-29 | |
| 8-K | 2023-11-15 | — |
Showing 1–50 of 113 filings
Key facts
CIK
1472012
CUSIP
45257U108
13F (30d)
192 filings
188 filers
Visit website
Investor relations